{"id":61869,"date":"2025-09-16T01:03:41","date_gmt":"2025-09-15T23:03:41","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/apimeds-expands-ai%c2%b2-future-labs-program-to-include-university-of-san-diego-students-in-biotech-business-development\/"},"modified":"2025-09-16T01:03:41","modified_gmt":"2025-09-15T23:03:41","slug":"apimeds-expands-ai%c2%b2-future-labs-program-to-include-university-of-san-diego-students-in-biotech-business-development","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/apimeds-expands-ai%c2%b2-future-labs-program-to-include-university-of-san-diego-students-in-biotech-business-development\/","title":{"rendered":"Apimeds Expands ai\u00b2 Future Labs Program to Include University of San Diego Students in Biotech Business Development"},"content":{"rendered":"
\n

MATAWAN, N.J.–(BUSINESS WIRE)–Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) (\u201cApimeds\u201d) today announced the expansion of its ai\u00b2 Future Labs program by engaging graduate students from the University of San Diego\u2019s Knauss School of Business. The initiative is designed to identify promising pharmaceutical assets critical to improving human health while cultivating the next generation of business leaders for the biopharmaceutical industry.<\/p>\n

\nFuture Labs is part of Apimeds\u2019 ai\u00b2 innovation platform, connecting university students with real-world strategy and business development projects. Through this collaboration, student teams will work closely with Apimeds mentors to identify and evaluate opportunities to advance development projects previously left behind by industry.<\/p>\n

\n\u201cWe\u2019re thrilled to welcome University of San Diego students into the Future Labs program,\u201d said Erik Emerson, CEO of Apimeds. \u201cUSD represents exactly the type of forward-thinking institution we want to partner with\u2014where students are encouraged to bring fresh perspectives to complex problems. Drug development is challenging, and many therapies with true potential never reach patients. Future Labs is meant to function as both a discovery engine for assets and a training ground for tomorrow\u2019s leaders.\u201d<\/p>\n

\nStudents will gain hands-on experience in market analysis, FDA regulations, clinical development requirements, competitive positioning, intellectual property, and commercialization planning\u2014skills that extend far beyond the classroom. Top-performing teams at each participating institution will be eligible for paid internships or consulting opportunities with Apimeds, creating a direct pathway into the industry.<\/p>\n

\n\u201cAs a recent graduate of the University of San Diego, I see Future Labs as an incredible way to take what we\u2019ve learned in the classroom and apply it directly to the challenges of the biopharma industry,\u201d said Coben Emerson, Manager, FP&A, Apimeds. \u201cBy working hands-on with asset evaluation and strategy, students not only contribute to Apimeds\u2019 pipeline exploration but also gain the kind of practical, career-ready experience that sets us apart as we enter the workforce.\u201d<\/p>\n

\n\u201cOur students will gain invaluable exposure to the business side of the life sciences industry,\u201d said Jaime Alonso Gomez, PhD, professor of strategy, international management and family business at the Knauss School of Business. \u201cPartnering with Apimeds allows us to deliver a one-of-a-kind experience\u2014where academic rigor meets real-world biopharma decision-making.\u201d<\/p>\n

\nThe initiative underscores Apimeds\u2019 commitment to fostering innovation, building meaningful industry\u2013academic collaborations, and shaping the next generation of biotech leaders.<\/p>\n

\nAbout Apimeds Pharmaceuticals<\/b><\/p>\n

\nApimeds Pharmaceuticals (NYSE American: APUS) is a clinical-stage biopharmaceutical company focused on developing non-opioid, biologic-based therapies for pain management. The company\u2019s lead product candidate, Apitox, is in late-stage clinical development for osteoarthritis of the knee. For more information visit www.apimedsus.com<\/a>. Information on the Apimeds\u2019 website does not constitute a part of and is not incorporated by reference into this press release.<\/p>\n

\nAbout the Knauss School of Business, University of San Diego<\/b><\/p>\n

\nThe Knauss School of Business at the University of San Diego is committed to developing socially responsible leaders with a global mindset through values-based education and innovative research. Together, we work to advance sustainable and ethical business solutions that address the world’s greatest challenges.<\/p>\n

\nForward-Looking Statements<\/b><\/p>\n

\nThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as \u201canticipate\u201d, \u201cbelieve\u201d, \u201cexpect\u201d, \u201cplan\u201d and \u201cwill\u201d are intended to identify forward-looking statements. Such forward-looking statements are based on the beliefs of management, as well as assumptions made by, and information currently available to, management. These statements relate only to events as of the date on which the statements are made, and Apimeds undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. All of the forward-looking statements made in this press release are qualified by these cautionary statements, and there can be no assurance that the actual results anticipated by Apimeds will be realized or, even if substantially realized, that they will have the expected consequences to or effects on the company or its business or operations. Readers are cautioned that certain important factors may affect Apimeds\u2019 actual results and could cause such results to differ materially from any forward-looking statements that may be made in this press release. Factors that may affect Apimeds\u2019 results include, but are not limited to, the ability of Apimeds to raise additional capital to finance its operations (whether through public or private equity offerings, debt financings, strategic collaborations or otherwise); risks relating to Apimeds\u2019 ability to advance its product candidate and successfully complete clinical trials; risks relating to its ability to hire and retain qualified personnel; and the additional risk factors described in Apimeds\u2019 filings with the U.S. Securities and Exchange Commission (the \u201cSEC\u201d), including its Annual Report on Form 10-K for the year ended December 31, 2024 as filed with the SEC on April 15, 2025 (as amended on May 2, 2025).<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia Contact:<\/b>
Brian Peters
\n
Apimeds Pharmaceuticals
\n
919-602-6557<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

MATAWAN, N.J.–(BUSINESS WIRE)–Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) (\u201cApimeds\u201d) today announced the expansion of its ai\u00b2 Future Labs program by engaging graduate students from the University of San Diego\u2019s Knauss School of Business. The initiative is designed to identify promising pharmaceutical assets critical to improving human health while cultivating the next generation of business … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-61869","6":"format-standard","7":"category-industry"},"yoast_head":"\nApimeds Expands ai\u00b2 Future Labs Program to Include University of San Diego Students in Biotech Business Development - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/apimeds-expands-ai\u00b2-future-labs-program-to-include-university-of-san-diego-students-in-biotech-business-development\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Apimeds Expands ai\u00b2 Future Labs Program to Include University of San Diego Students in Biotech Business Development - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"MATAWAN, N.J.–(BUSINESS WIRE)–Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) (\u201cApimeds\u201d) today announced the expansion of its ai\u00b2 Future Labs program by engaging graduate students from the University of San Diego\u2019s Knauss School of Business. The initiative is designed to identify promising pharmaceutical assets critical to improving human health while cultivating the next generation of business ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/apimeds-expands-ai\u00b2-future-labs-program-to-include-university-of-san-diego-students-in-biotech-business-development\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-15T23:03:41+00:00\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/apimeds-expands-ai%c2%b2-future-labs-program-to-include-university-of-san-diego-students-in-biotech-business-development\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/apimeds-expands-ai%c2%b2-future-labs-program-to-include-university-of-san-diego-students-in-biotech-business-development\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Apimeds Expands ai\u00b2 Future Labs Program to Include University of San Diego Students in Biotech Business Development\",\"datePublished\":\"2025-09-15T23:03:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/apimeds-expands-ai%c2%b2-future-labs-program-to-include-university-of-san-diego-students-in-biotech-business-development\\\/\"},\"wordCount\":857,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/apimeds-expands-ai%c2%b2-future-labs-program-to-include-university-of-san-diego-students-in-biotech-business-development\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/apimeds-expands-ai%c2%b2-future-labs-program-to-include-university-of-san-diego-students-in-biotech-business-development\\\/\",\"name\":\"Apimeds Expands ai\u00b2 Future Labs Program to Include University of San Diego Students in Biotech Business Development - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"datePublished\":\"2025-09-15T23:03:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/apimeds-expands-ai%c2%b2-future-labs-program-to-include-university-of-san-diego-students-in-biotech-business-development\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/apimeds-expands-ai%c2%b2-future-labs-program-to-include-university-of-san-diego-students-in-biotech-business-development\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/apimeds-expands-ai%c2%b2-future-labs-program-to-include-university-of-san-diego-students-in-biotech-business-development\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Apimeds Expands ai\u00b2 Future Labs Program to Include University of San Diego Students in Biotech Business Development\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Apimeds Expands ai\u00b2 Future Labs Program to Include University of San Diego Students in Biotech Business Development - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/apimeds-expands-ai\u00b2-future-labs-program-to-include-university-of-san-diego-students-in-biotech-business-development\/","og_locale":"en_US","og_type":"article","og_title":"Apimeds Expands ai\u00b2 Future Labs Program to Include University of San Diego Students in Biotech Business Development - Pharma Trend","og_description":"MATAWAN, N.J.–(BUSINESS WIRE)–Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) (\u201cApimeds\u201d) today announced the expansion of its ai\u00b2 Future Labs program by engaging graduate students from the University of San Diego\u2019s Knauss School of Business. The initiative is designed to identify promising pharmaceutical assets critical to improving human health while cultivating the next generation of business ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/apimeds-expands-ai\u00b2-future-labs-program-to-include-university-of-san-diego-students-in-biotech-business-development\/","og_site_name":"Pharma Trend","article_published_time":"2025-09-15T23:03:41+00:00","author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/apimeds-expands-ai%c2%b2-future-labs-program-to-include-university-of-san-diego-students-in-biotech-business-development\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/apimeds-expands-ai%c2%b2-future-labs-program-to-include-university-of-san-diego-students-in-biotech-business-development\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Apimeds Expands ai\u00b2 Future Labs Program to Include University of San Diego Students in Biotech Business Development","datePublished":"2025-09-15T23:03:41+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/apimeds-expands-ai%c2%b2-future-labs-program-to-include-university-of-san-diego-students-in-biotech-business-development\/"},"wordCount":857,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/apimeds-expands-ai%c2%b2-future-labs-program-to-include-university-of-san-diego-students-in-biotech-business-development\/","url":"https:\/\/pharma-trend.com\/en\/apimeds-expands-ai%c2%b2-future-labs-program-to-include-university-of-san-diego-students-in-biotech-business-development\/","name":"Apimeds Expands ai\u00b2 Future Labs Program to Include University of San Diego Students in Biotech Business Development - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"datePublished":"2025-09-15T23:03:41+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/apimeds-expands-ai%c2%b2-future-labs-program-to-include-university-of-san-diego-students-in-biotech-business-development\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/apimeds-expands-ai%c2%b2-future-labs-program-to-include-university-of-san-diego-students-in-biotech-business-development\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/apimeds-expands-ai%c2%b2-future-labs-program-to-include-university-of-san-diego-students-in-biotech-business-development\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Apimeds Expands ai\u00b2 Future Labs Program to Include University of San Diego Students in Biotech Business Development"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61869","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=61869"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61869\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=61869"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=61869"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=61869"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}